Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD): (553842013-001)
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Objectives To assess efficacy, comparative effectiveness, and harms of psychological and pharmacological treatments for adults with posttraumatic stress disorder (PTSD). Data sources MEDLINE®, Cochrane Library, PILOTS, International Pharmaceutical Abstracts, CINAHL®, PsycINFO®, Web of Science, Embase, U.S. Food and Drug Administration Web site, and reference lists of published literature (January 1980–May 2012). Review methods Two investigators independently selected, extracted data from, and rated risk of bias of relevant trials. We conducted quantitative analyses using random-effects models to estimate pooled effects. To estimate medications’ comparative effectiveness, we conducted a network meta-analysis using Bayesian methods. We graded strength of evidence (SOE) based on established guidance. Results We included 92 trials of patients, generally with severe PTSD and mean age of 30s to 40s. High SOE supports efficacy of exposure therapy for improving PTSD symptoms (Cohen’s d −1.27; 95% confidence interval, −1.54 to −1.00); number needed to treat (NNT) to achieve loss of diagnosis was 2 (moderate SOE). Evidence also supports efficacy of cognitive processing therapy (CPT), cognitive therapy (CT), cognitive behavioral therapy (CBT)-mixed therapies, eye movement desensitization and reprocessing (EMDR), and narrative exposure therapy for improving PTSD symptoms and/or achieving loss of diagnosis (moderate SOE). Effect sizes for reducing PTSD symptoms were large (e.g., 28.9- to…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Rates of participants who no longer met PTSD diagnosis criteria ranged from 30% to 97% and 51% more participants treated with CPT achieved loss of PTSD diagnosis, compared to waitlist, self-help booklet and usual care control groups (Jonas et al., 2013).”
From Treating PTSD: A Review of Evidence-Based Psychotherapy Interventions (2018) · cites this paper as Jonas et al., 2013
In the citing paper
“In addition, 66% more participants treated with exposure therapy achieved loss of PTSD diagnosis than in waitlist control groups (Jonas et al., 2013).”
From Treating PTSD: A Review of Evidence-Based Psychotherapy Interventions (2018) · cites this paper as Jonas et al., 2013
In the citing paper
“Among PE participants, 41% to 95% lost their PTSD diagnosis at the end of treatment (Jonas et al., 2013).”
From Treating PTSD: A Review of Evidence-Based Psychotherapy Interventions (2018) · cites this paper as Jonas et al., 2013
In the citing paper
“Rates of participants who no longer met PTSD diagnosis criteria ranged from 30% to 97% and 51% more participants treated with CPT achieved loss of PTSD diagnosis, compared to waitlist, self-help booklet and usual care control groups (Jonas et al., 2013).”
From Treating PTSD: A Review of Evidence-Based Psychotherapy Interventions (2018) · cites this paper as Jonas et al., 2013
Citations
Cites
Combat Duty in Iraq and Afghanistan, Mental Health Problems, and Barriers to Care
Hoge, C. W., Castro, C. A., Messer, S. C., McGurk, D., Cotting, D. I., & Koffman, R. L. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040603 · Cited by 4,778
Clinician-administered PTSD scale: A review of the first ten years of research
Weathers, F. W., Keane, T. M., & Davidson, J. R. T. (2001) · Depression and Anxiety · doi:10.1002/da.1029 · Cited by 1,901 · cited 1×
“For example, some suggest that a reduction of 15 points on the Clinician-Administered PTSD Scale (CAPS) constitutes a clinically significant reduction.(27) However, this cutoff has not been validated and is somewhat uncertain.”
Background(2008) · RAND Corporation eBooks · doi:10.7249/mg720 · Cited by 1,712 · cited 1×
“, the Veterans Health Administration [VA]) have identified PTSD as a priority area for quality improvement and comparative effectiveness research; these decisions are based, in part, on evidence of higher rates of PTSD among service members returning from operations in Afghanistan and Iraq than previously reported, an…”
BackgroundFreeman, A. M. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1112 · Cited by 1,666
Seal (2007) · doi:10.1001/archinte.167.5.476 · Cited by 936 · cited 1×
“6 percent for those who fought in Iraq (see Figure 3).(8)”
BackgroundFoa, E. B., Hembree, E. A., Cahill, S. P., Rauch, S. A. M., Riggs, D. S., Feeny, N. C., & Yadin, E. (2005) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.73.5.953 · Cited by 931
(2000) · PubMed · Cited by 858
The theory and practice of group psychotherapy, 4th ed.
Yalom, I. D., & Leszcz, M. (1995) · Cited by 706
The Psychological Risks of Vietnam for U.S. Veterans: A Revisit with New Data and Methods
Dohrenwend, B. P., Turner, J. B., Turse, N. A., Adams, B. G., Koenen, K. C., & Marshall, R. (2006) · Science · doi:10.1126/science.1128944 · Cited by 689 · cited 2×
“1 percent among Vietnam veterans.(7) Surveys of military personnel returning from operations in Afghanistan and Iraq have yielded estimates ranging from 6.”
Background(1993) · Medical Entomology and Zoology · Cited by 611
Cited by
Treating PTSD: A Review of Evidence-Based Psychotherapy Interventions
Watkins, L. E., Sprang, K. R., & Rothbaum, B. O. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00258 · Cited by 563
“In addition, 66% more participants treated with exposure therapy achieved loss of PTSD diagnosis than in waitlist control groups (Jonas et al., 2013).”
BackgroundMethodInfluentialMental Health Response to Community Disasters: A Systematic Review
North, C. S., & Pfefferbaum, B. (2013) · JAMA · doi:10.1001/jama.2013.107799 · Cited by 549
Lewis, C., Roberts, N. P., Andrew, M., Starling, E., & Bisson, J. I. (2020) · European Journal of Psychotraumatology · doi:10.1080/20008198.2020.1729633 · Cited by 460
“…the traumatic event and those that aim to reduce traumatic stress symptoms without directly targeting the traumamemory or related thoughts, with the strongest evidence for the effect of those with a trauma-focus (Bisson et al., 2013; Bradley et al., 2005; Cusack et al., 2006; Jonas et al., 2013).”
BackgroundPharmacotherapy for post-traumatic stress disorder: Systematic review and meta-analysis
Hoskins, M., Pearce, J., Bethell, A., Dankova, L., Barbui, C., Tol, W. A., van Ommeren, M., de Jong, J., Seedat, S., Chen, H., et al. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.148551 · Cited by 418
Lewis, C., Roberts, N. P., Gibson, S., & Bisson, J. I. (2020) · European Journal of Psychotraumatology · doi:10.1080/20008198.2019.1709709 · Cited by 382
“However, there is evidence that the absence of a trauma-focus results in poorer outcomes (Bisson et al., 2013; Bradley et al., 2005; Jonas et al., 2013).”
BackgroundExposure therapy for PTSD: A meta-analysis
McLean, C. P., Levy, H. C., Miller, M. L., & Tolin, D. F. (2022) · Clinical Psychology Review · doi:10.1016/j.cpr.2021.102115 · Cited by 273
A guide to guidelines for the treatment of posttraumatic stress disorder in adults: An update
Hamblen, J. L., Norman, S. B., Sonis, J. H., Phelps, A. J., Bisson, J. I., Nunes, V. D., Megnin-Viggars, O., Forbes, D., Riggs, D. S., & Schnurr, P. P. (2019) · Psychotherapy · doi:10.1037/pst0000231 · Cited by 264
Self-citationEMDR beyond PTSD: A Systematic Literature Review
Valiente-Gómez, A., Moreno-Alcázar, A., Treen, D., Cedrón, C., Colom, F., Pérez, V., & Amann, B. L. (2017) · Frontiers in Psychology · doi:10.3389/fpsyg.2017.01668 · Cited by 184
Merz, J., Schwarzer, G., & Gerger, H. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.0951 · Cited by 166
Posttraumatic stress disorder: from diagnosis to prevention
Miao, X.-R., Chen, Q.-B., Wei, K., Tao, K.-M., & Lu, Z.-J. (2018) · Military Medical Research · doi:10.1186/s40779-018-0179-0 · Cited by 161
“As for the comparative evidence of psychological with pharmacological treatments or combinations of psychological treatments and pharmacological treatments with other treatments, evidence was insufficient to draw any firm conclusions [40].”
BackgroundMethodInfluentialCipriani, A., Williams, T., Nikolakopoulou, A., Salanti, G., Chaimani, A., Ipser, J., Cowen, P. J., Geddes, J. R., & Stein, D. J. (2018) · Psychological Medicine · doi:10.1017/s003329171700349x · Cited by 149
“Treatments available for PTSD span a variety of psychological and pharmacological interventions (Jonas et al. 2013).”
BackgroundInterventions to Prevent Post-Traumatic Stress Disorder
Forneris, C. A., Gartlehner, G., Brownley, K. A., Gaynes, B. N., Sonis, J. H., Coker‐Schwimmer, E., Jonas, D. E., Greenblatt, A. M., Wilkins, T. M., Woodell, C., et al. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2013.02.013 · Cited by 165
Self-citationSerova, L. I., Lauková, M., Alaluf, L. G., Pucillo, L., & Sabban, E. L. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.11.007 · Cited by 139
“Network meta-analysis of pooled data from 92 trials revealed that the medications used have only moderate strength of evidence supporting their effectiveness [review in Jonas et al. (2013)].”
MethodSpoont, M. R., Nelson, D. B., Murdoch, M., Sayer, N. A., Nugent, S., Rector, T., & Westermeyer, J. (2015) · Depression and Anxiety · doi:10.1002/da.22295 · Cited by 122
Widge, A. S., Ellard, K. K., Paulk, A. C., Basu, I., Yousefi, A., Zorowitz, S., Gilmour, A., Afzal, A., Deckersbach, T., Cash, S. S., et al. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2016.07.021 · Cited by 118
“Serotonin reuptake inhibitors (SRIs), the mainstay of evidencebased pharmacology for anxiety, have modest efficacy at best (Jonas et al., 2013).”
Flanagan, J. C., Sippel, L. M., Wahlquist, A., Moran-Santa Maria, M. M., & Back, S. E. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.12.014 · Cited by 117
“Larger randomized controlled trials of PE similarly show large effects, but have also revealed a subset of patients who show limited or no benefit (Jonas et al., 2013).”
Schnurr, P. P., & Lunney, C. A. (2016) · Depression and Anxiety · doi:10.1002/da.22477 · Cited by 105
“A recent review calls attention to this as a problem in veteran and military samples,[47] but other analyses show that a number of nonveterans also do not achieve optimal endpoints.[44, 48] However, a recent study shows that long-term meaningful improvement is possible.”
BackgroundTanielian, T., Farris, C., Batka, C., Farmer, C., Robinson, E., Engel, C., Robbins, M., & Jaycox, L. (2014) · RAND Corporation eBooks · doi:10.7249/rr806 · Cited by 105
Prevention of trauma and stressor-related disorders: A review
Howlett, J. R., & Stein, M. B. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.261 · Cited by 102
“Several SSRIs have shown efficacy in the treatment of chronic PTSD (Jonas et al, 2013).”
BackgroundZatzick, D., Jurkovich, G. J., Heagerty, P. J., Russo, J. E., Darnell, D. A., Parker, L. E., Roberts, M. K., Moodliar, R., Engstrom, A., Wang, J., et al. (2021) · JAMA Surgery · doi:10.1001/jamasurg.2021.0131 · Cited by 111
Spoont, M. R., Williams, J. W., Kehle-Forbes, S., Nieuwsma, J. A., Mann-Wrobel, M. C., & Gross, R. (2015) · JAMA · doi:10.1001/jama.2015.7877 · Cited by 93
Bernardy, N. C., & Friedman, M. J. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0564-2 · Cited by 105
Mulvaney, S. W., Lynch, J. H., Hickey, M., Rahman-Rawlins, T., Schroeder, M. J., Kane, S. F., & Lipov, E. (2014) · Military Medicine · doi:10.7205/milmed-d-14-00151 · Cited by 101
“Other pharmacological interventions include topiramate and venlafazine, but the effectiveness varies.(7,8) Prazosin has been used to manage nightmares.”
BackgroundLewis, C., Roberts, N. P., Simon, N., Bethell, A., & Bisson, J. I. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13079 · Cited by 91
A Pilot Study of Neurofeedback for Chronic PTSD
Gapen, M., van der Kolk, B. A., Hamlin, E., Hirshberg, L., Suvak, M. K., & Spinazzola, J. (2016) · Applied Psychophysiology and Biofeedback · doi:10.1007/s10484-015-9326-5 · Cited by 97
Lewis, C. E., Farewell, D., Groves, V., Kitchiner, N. J., Roberts, N. P., Vick, T., & Bisson, J. I. (2017) · Depression and Anxiety · doi:10.1002/da.22645 · Cited by 84
“Effect sizes were comparable to those reported for therapist administered trauma-focused psychological treatments for PTSD (Jonas et al., 2013).”
BackgroundResultLatest developments in post-traumatic stress disorder: diagnosis and treatment: Table 1
Greenberg, N., Brooks, S., & Dunn, R. (2015) · British Medical Bulletin · doi:10.1093/bmb/ldv014 · Cited by 74
“Instead, as stated above, provision of good social support and a temporary reduction in exposure to stressors is likely to aid recovery in most cases.(26) A minority of individuals will however suffer with most intense and impairing symptoms which are diagnostically referred to as acute stress disorder for the first m…”
BackgroundMethodWang, S.-C., Lin, C.-C., Chen, C.-C., Tzeng, N., & Liu, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123848 · Cited by 79
“Posttraumatic stress disorder (PTSD) is a mental disorder characterized by fear memory abnormalities in individuals who have previously experienced a traumatic event [1,2].”
New Developments in Intimate Partner Violence and Management of Its Mental Health Sequelae
Stewart, D. E., Vigod, S. N., & Riazantseva, E. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0644-3 · Cited by 83
Trauma-Focused Art Therapy in the Treatment of Posttraumatic Stress Disorder: A Pilot Study
Schouten, K. A., van Hooren, S., Knipscheer, J. W., Kleber, R. J., & Hutschemaekers, G. J. M. (2019) · Journal of Trauma & Dissociation · doi:10.1080/15299732.2018.1502712 · Cited by 71
“For these patients, no alternative evidence-based treatments are available yet (Bisson et al., 2007; Jonas et al., 2013).”
BackgroundLi, H., Su, P., Lai, T. K. Y., Jiang, A., Liu, J., Zhai, D., Campbell, C., Lee, F. H. F., Yong, W., Pasricha, S., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci130363 · Cited by 80
“Others have suggested that dissociation of the GR-FKBP51 complex would promote GR-FKBP52 complex formation, leading to GR nuclear translocation, where GR can activate or repress transcription of target genes (36).”
BackgroundTreatment-refractory posttraumatic stress disorder (TRPTSD): a review and framework for the future
Koek, R. J., Schwartz, H. N., Scully, S., Langevin, J., Spangler, S. L., Korotinsky, A., Jou, K., & Leuchter, A. F. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.01.015 · Cited by 81
Brown, L. C., Murphy, A. R., Lalonde, C. S., Subhedar, P. D., Miller, A. H., & Stevens, J. S. (2020) · Cancer · doi:10.1002/cncr.32934 · Cited by 68
Treatment of Sleep Disturbances in Post-Traumatic Stress Disorder: A Review of the Literature
Brownlow, J. A., Harb, G. C., & Ross, R. J. M. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0587-8 · Cited by 73
Bell, A. N., Moss, D., & Kallmeyer, R. J. (2019) · NeuroRegulation · doi:10.15540/nr.6.2.54 · Cited by 65
“Meta-analyses have found the latter three to produce mild to moderate effects in 60% of participants (Bradley, Greene, Russ, Dutra & Westen, 2005; Erford et al., 2016; Hoskins et al., 2015; Jonas et al., 2013; Swift & Greenberg, 2012).”
BackgroundHake, H. S., Davis, J. K. P., Wood, R. R., Tanner, M. K., Loetz, E. C., Sanchez, A., Ostrovskyy, M., Oleson, E. B., Grigsby, J., Doblin, R., et al. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.12.007 · Cited by 66
Fiorillo, D., McLean, C., Pistorello, J., Hayes, S. C., & Follette, V. M. (2017) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2016.11.003 · Cited by 61
Ahmadizadeh, M. J., Rezaei, M., & Fitzgerald, P. B. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.09.011 · Cited by 74
PTSD and comorbid AUD: a review of pharmacological and alternative treatment options
Petrakis, I. L., Ralevski, E., & Olivera-Figueroa, L. A. (2014) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s37399 · Cited by 73
Considering future pharmacotherapy for PTSD
Friedman, M. J., & Bernardy, N. C. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.11.048 · Cited by 64
“Likewise, we might predict that SSRIs/SNRIs and other antidepressants that potentiate adrenergic and/or serotonergic activity might selectively benefit PTSD patients with the dysphoric/anhedonic phenotype, but not others.”
Backgroundvan Gelderen, M. J., Nijdam, M. J., & Vermetten, E. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00176 · Cited by 56
A Review of Stellate Ganglion Block as an Adjunctive Treatment Modality
Kirkpatrick, K. P., Khan, M. H., Deng, Y., & Shah, K. B. (2023) · Cureus · doi:10.7759/cureus.35174 · Cited by 81
“Conventional treatment typically involves psychotherapy and medication, with an overall rate of remission of 30-40% [28], suggesting the need for more innovative approaches.”
Shiner, B., Leonard Westgate, C., Bernardy, N. C., Schnurr, P. P., & Watts, B. V. (2017) · Journal of Dual Diagnosis · doi:10.1080/15504263.2017.1325033 · Cited by 54
“substance abuse treatment; inpatient admission for detoxification; and whether patients received an antidepressant that is effective for PTSD, including fluoxetine, sertraline, paroxetine, or venlafaxine (Jonas et al., 2013; Watts et al., 2013).”
BackgroundMeredith, L. S., Eisenman, D. P., Han, B., Green, B. L., Kaltman, S. I., Wong, E. C., Sorbero, M. E. S., Vaughan, C., Cassells, A. N., Zatzick, D., et al. (2016) · Journal of General Internal Medicine · doi:10.1007/s11606-016-3588-3 · Cited by 59
Quality of Care for PTSD and Depression in the Military Health System: Final Report
Hepner, K. A., Roth, C. P., Sloss, E. M., Paddock, S. M., Iyiewuare, P. O., Timmer, M. M., & Pincus, H. A. (2017) · Rand health quarterly · doi:10.7249/rhq-07-03-04 · Cited by 49
Estradiol modulation of the renin–angiotensin system and the regulation of fear extinction
Parrish, J. N., Bertholomey, M. L., Pang, H. W., Speth, R. C., & Torregrossa, M. M. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0374-0 · Cited by 54
Murphy, D., Hodgman, G., Carson, C., Spencer-Harper, L., Hinton, M., Wessely, S. C., & Busuttil, W. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-007051 · Cited by 56
Belleville, G., Dubé‐Frenette, M., & Rousseau, A. (2018) · Journal of Traumatic Stress · doi:10.1002/jts.22306 · Cited by 48
Pedraza, L. K., Sierra, R. O., Giachero, M., Nunes, W. S., Lotz, F. N., & Alvares, L. D. O. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0371-3 · Cited by 49
Influence of Sleep Disturbance on Global Functioning After Posttraumatic Stress Disorder Treatment
Brownlow, J. A., McLean, C. P., Gehrman, P. R., Harb, G. C., Ross, R. J., & Foa, E. B. (2016) · Journal of Traumatic Stress · doi:10.1002/jts.22139 · Cited by 45
Mental Health Aspects of Intimate Partner Violence
Stewart, D. E., & Vigod, S. N. (2017) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2017.01.009 · Cited by 56
Flanagan, J. C., Hand, A., Jarnecke, A. M., Maria, M. M. M., Brady, K. T., & Joseph, J. E. (2018) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000197 · Cited by 48
“However, there remains a scarcity of effective pharmacological treatments available (Jonas et al., 2013; The Management of Posttraumatic Stress Disorder Work Group, 2017).”
Fruchtman-Steinbok, T., Keynan, J. N., Cohen, A., Jaljuli, I., Mermelstein, S., Drori, G., Routledge, E., Krasnoshtein, M., Playle, R., Linden, D. E. J., et al. (2021) · NeuroImage: Clinical · doi:10.1016/j.nicl.2021.102859 · Cited by 42
“…showed that prolonged exposure therapy (PE) in PTSD out-performed control conditions with a similarly large effect size (Hedges ’ s g = 1.08, 95% CI 0.69 to 1.46) (Powers et al., 2010), and with reported NNT ≤ 4 for achieving loss of PTSD diagnosis following psychotherapy (Jonas, et al., 2013).”
InfluentialMDMA as a Probe and Treatment for Social Behaviors
Heifets, B. D., & Malenka, R. C. (2016) · Cell · doi:10.1016/j.cell.2016.06.045 · Cited by 42
“This mode of therapy can be remarkably effective for simple fears, such as a pathological fear of heights, but in the context of PTSD, it is marginally effective, producing an estimated remission rate of only 20%–30% above placebo (Jonas et al., 2013).”
BackgroundSchnurr, P. P., Chard, K. M., Ruzek, J. I., Chow, B. K., Shih, M., Resick, P. A., Foa, E. B., Marx, B. P., Huang, G. D., & Lü, Y. (2014) · Contemporary Clinical Trials · doi:10.1016/j.cct.2014.11.017 · Cited by 46
Defining Treatment-Resistant Posttraumatic Stress Disorder: A Framework for Future Research
Sippel, L. M., Holtzheimer, P. E., Friedman, M. J., & Schnurr, P. P. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.03.011 · Cited by 47
Sánchez, S. E., Pineda, O., Chaves, D. Z., Zhong, Q., Gelaye, B., Simon, G. E., Rondón, M. B., & Williams, M. A. (2017) · Annals of Epidemiology · doi:10.1016/j.annepidem.2017.09.012 · Cited by 49
Fazel, M. S., Stratford, H. J., Rowsell, E., Chan, C., Griffiths, H., & Robjant, K. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00019 · Cited by 45
Maples‐Keller, J. L., Price, M., Rauch, S. A. M., Gerardi, M. A., & Rothbaum, B. O. (2016) · Behavior Therapy · doi:10.1016/j.beth.2016.02.011 · Cited by 42
“While a strong empirical basis for exposure-based treatments for PTSD exists (Jonas et al., 2013; Powers, Halpern, Ferenschak, Gillihan, & Foa, 2010), there is a lack of research regarding the therapeutic process across the clusters of symptoms.”
Risk of Recidivism Among Justice-Involved Veterans: A Systematic Review of the Literature
Blonigen, D. M., Bui, L., Elbogen, E. B., Blodgett, J. C., Maisel, N. C., Midboe, A. M., Asch, S. M., McGuire, J. F., & Timko, C. (2014) · Criminal Justice Policy Review · doi:10.1177/0887403414562602 · Cited by 47
“To the extent there are veteran-specific criminogenic needs, the evidence supports the role of combat-related PTSD and TBI in risk for violent offending, particularly among recent returnees from Iraq and Afghanistan and when combined with anger/irritability.”
BackgroundInfluentialGuidelines for the Reporting of Treatment Trials for Alcohol Use Disorders
Witkiewitz, K., Finney, J. W., Harris, A. H. S., Kivlahan, D. R., & Kranzler, H. R. (2015) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12797 · Cited by 37
“Reporting on adverse events is commonly lacking in nonpharmacological trials (Jonas et al., 2013), but is essential in grading the evidence in terms of relative harms and benefits as part of systematic reviews.”
BackgroundEMDR for Depression: A Meta-Analysis and Systematic Review
Sepehry, A. A., Lam, K., Sheppard, M., Guirguis‐Younger, M., & Maglio, A.-S. (2021) · Journal of EMDR Practice and Research · doi:10.1891/emdr-d-20-00038 · Cited by 45
Psychiatric consultation in the collaborative care model: The “bipolar sieve” effect
Phelps, J. R., & James, J. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.06.017 · Cited by 36
Shishko, I., Oliveira, R., Moore, T. A., & Almeida, K. (2018) · Mental Health Clinician · doi:10.9740/mhc.2018.03.086 · Cited by 40
“However, the number needed to treat with preferred antidepressants for a response is up to 9 patients.(7) Remission rates with pharmacotherapy have been reported to be 20% to 30%.”
BackgroundDefining focal brain stimulation targets for PTSD using neuroimaging
van Rooij, S. J. H., Sippel, L. M., McDonald, W. M., & Holtzheimer, P. E. (2021) · Depression and Anxiety · doi:10.1002/da.23159 · Cited by 38
Translation of animal endocannabinoid models of PTSD mechanisms to humans: Where to next?
Ney, L. J., Crombie, K. M., Mayo, L. M., Felmingham, K. L., Bowser, T. A., & Matthews, A. J. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.11.040 · Cited by 33
Current Reports on Perinatal Intimate Partner Violence
Stewart, D., Vigod, S., Macmillan, H., Chandra, P., Han, A., Rondon, M., MacGregor, J. C. D., & Riazantseva, E. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0778-6 · Cited by 25
Tegeler, C. H., Cook, J., Tegeler, C. L., Hirsch, J. R., Shaltout, H. A., Simpson, S. L., Fidali, B. C., Gerdes, L., & Lee, S. W. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1299-x · Cited by 32
“traumatic event, are the most evidence-based treatment [1, 2].”
BackgroundPharmacotherapies for Posttraumatic Stress Disorder: A Meta-Analysis
Gu, W., Wang, C., Li, Z., Wang, Z., & Zhang, X. (2016) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000478 · Cited by 31
“A proportion of patients with PTSD are not effectively treated with behavioral therapy or cognitive-behavioral therapy, and pharmacotherapy is important in these patients (Health, NCCfM, 2005; Jonas et al., 2013).”
BackgroundMethodTang, V. M., Trought, K., Gicas, K. M., Kozak, M., Josselyn, S. A., Daskalakis, Z. J., Blumberger, D. M., Voineskos, D., Knyahnytska, Y., Pasricha, S., et al. (2021) · Brain stimulation · doi:10.1016/j.brs.2021.03.015 · Cited by 28
Update on Mental Health Aspects of Intimate Partner Violence
Stewart, D. E., & Vigod, S. N. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2019.02.010 · Cited by 39
Latif, M., Husain, M. I., Gul, M., Naz, S., Irfan, M., Aslam, M., Awan, F., Sharif, A., Rathod, S., Farooq, S., et al. (2020) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465820000685 · Cited by 30
“There is robust evidence that therapist-delivered trauma-focused CBT is useful for the treatment of PTSD (Bisson et al., 2013; Jonas et al., 2013) and can be used in a brief format (Wu et al., 2014).”
BackgroundHuman Brain Disorders: A Review
Naz, F., & Siddique, Y. H. (2020) · The Open Biology Journal · doi:10.2174/1874196702008010006 · Cited by 34
Lin, C.-C., Cheng, P., Hsiao, M., & Liu, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105494 · Cited by 29
“Posttraumatic stress disorder (PTSD) is a mental disorder involving fear memory abnormalities [1,2].”
BackgroundHarpaz‐Rotem, I., Rosenheck, R. A., Mohamed, S., Pietrzak, R. H., & Hoff, R. A. (2016) · BJPsych Open · doi:10.1192/bjpo.bp.115.002451 · Cited by 25
“1,2 Therefore, it may be useful to identify clinical predictors of the choice of psychotropic medication in the treatment of PTSD in clinical settings, especially early in treatment to identify the association of specific symptom patterns with use of specific agents.”
Williams, T., Stein, D. J., & Ipser, J. (2018) · Evidence-Based Mental Health · doi:10.1136/eb-2017-102718 · Cited by 23
Veen, C., Jacobs, G., Philippens, I., & Vermetten, E. (2018) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2017_34 · Cited by 23
Szpringer, M., Oledzka, M., & Amann, B. L. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.00785 · Cited by 22
“The efficacy of EMDR for PTSD has undergone the scrutiny of various metaanalyses (Van Etten and Taylor, 1998; Davidson and Parker, 2001; Bradley et al., 2005; Seidler and Wagner, 2006; Bisson and Andrew, 2007; Benish et al., 2008; Jonas et al., 2013; Chen et al., 2014, 2015; Cusack et al., 2016).”
BackgroundSurís, A., Holliday, R. P., Adinoff, B. H., Holder, N. D., & North, C. S. (2017) · Psychiatry · doi:10.1080/00332747.2017.1286892 · Cited by 25
“, selective serotonin reuptake inhibitors [SSRIs]) are effective for some but not all individuals with PTSD (Jonas et al., 2013).”
BackgroundInfluentialPérez, A. D. A., Popik, B., & Alvares, L. D. O. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108107 · Cited by 21
Early responding to traumatic events
Bisson, J. I. (2014) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.113.136077 · Cited by 25
Lin, C.-C., Huang, K., Tung, C., & Liu, Y. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.07.014 · Cited by 24
“Posttraumatic stress disorder (PTSD) is a mental disorder with anxiety symptoms and fear memory abnormalities triggered in individuals who have experienced a traumatic event [1,2].”
Mitochondrial DNA as a marker for treatment-response in post-traumatic stress disorder
Hummel, E. M., Piovesan, K., Berg, F., Herpertz, S., Kessler, H., Kumsta, R., & Moser, D. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105993 · Cited by 22
Spangler, P. T., West, J. C., Dempsey, C. L., Possemato, K., Bartolanzo, D., Aliaga, P. A., Zarate, C. A., Vythilingam, M., & Benedek, D. M. (2020) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.20m13233 · Cited by 21
“Results for the main effect for treatment group on change in PCL were (F(1, 69) = 2.”
BackgroundShiner, B. R., Westgate, C. L., Gui, J., Cornelius, S. L., Maguen, S., Watts, B. V., & Schnurr, P. P. (2019) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-019-01004-2 · Cited by 20
“For patients who received one of the four effective antidepressants for PTSD, we determined whether they received an adequate treatment, which we defined as eight weeks of a daily dose at least as high as the dose used in the efficacy trials supporting the treatment recommendation (Jonas et al. 2013; Watts et al. 2013…”
MethodScheuer, H., Engstrom, A., Thomas, P., Moodliar, R., Moloney, K., Walen, M. L., Johnson, P., Seo, S., Vaziri, N., Martinez, A., et al. (2020) · Contemporary Clinical Trials · doi:10.1016/j.cct.2020.105970 · Cited by 18
Post-Traumatic Stress Disorder
Chavez, B., & Kavanagh, K. (2017) · The American Pharmacists Association eBooks · doi:10.21019/pharmacotherapyfirst.ptsd_overview · Cited by 18
Integrating EMDR in psychotherapy.
Balbo, M., Cavallo, F., & Fernández, I. (2019) · Journal of Psychotherapy Integration · doi:10.1037/int0000136 · Cited by 23
“The effectiveness of EMDR therapy in treating PTSD has undergone the scrutiny of several meta-analyses (Benish, Imel, & Wampold, 2008; Bradley, Greene, Russ, Dutra, & Westen, 2005; Chen, Zhang, Hu, & Liang, 2015; Davidson & Parker, 2001; Jonas et al., 2013; Seidler & Wagner, 2006; Van Etten & Taylor, 1998), and the Wo…”
BackgroundUnderstanding psychological and collective trauma related to neighborhood violence
Tuller, L. R. (2020) · Digital Repository Service (Northeastern University) · doi:10.17760/d20384387 · Cited by 20
Protocol for individual participant data meta-analysis of interventions for post-traumatic stress
Wright, S. L., Karyotaki, E., Bisson, J. I., Cuijpers, P. J., Papola, D., Witteveen, A. B., Seedat, S., & Sijbrandij, M. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-054830 · Cited by 17
Novel Pharmacological Targets of Post-Traumatic Stress Disorders
Marazziti, D., Carmassi, C., Cappellato, G., Chiarantini, I., Massoni, L., Mucci, F., Arone, A., Violi, M., Palermo, S., Iorio, G. D., et al. (2023) · Life · doi:10.3390/life13081731 · Cited by 24
Liu, Y., Steinhausen, K., Bharwani, A., Mian, M. F., Neufeld, K. M., & Forsythe, P. (2020) · Scientific Reports · doi:10.1038/s41598-020-69968-y · Cited by 23
Ketamine treatment upon memory retrieval reduces fear memory in marmoset monkeys
Philippens, I. H. C. H. M., Draaisma, L. R., Baarends, G., Krugers, H. J., & Vermetten, E. H. G. J. M. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.04.004 · Cited by 17
“Despite research efforts to develop more effective therapies, PTSD remains difficult to treat ( Jonas et al., 2018 ; Lee et al., 2016 ).”
Halfond, R. W., Wright, C. V., & Bufka, L. F. (2020) · Clinical Psychology Science and Practice · doi:10.1111/cpsp.12343 · Cited by 20
Zhang, Z., Liu, R.-B., Zhang, J., Xian‐Yu, C., Liu, J.-L., Li, X., Zhang, Y., & Zhang, C. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110754 · Cited by 17
Condensed Internet-delivered prolonged exposure provided soon after trauma: a randomised trial
Bragesjö, M., Arnberg, F. K., Lauri, K. O., Aspvall, K., Särnholm, J., & Andersson, E. (2021) · Psychological Medicine · doi:10.1017/s0033291721003706 · Cited by 17
“There are concerns among clinicians that exposure-based interventions may not be tolerable for many trauma-afflicted individuals (Deacon & Farrell, 2013; Jonas et al., 2013).”
Pathways from victimization to substance use: Post traumatic stress disorder as a mediator
Lee, J. Y., Brook, J. S., Finch, S. J., & Brook, D. W. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.01.049 · Cited by 16
“In addition, pharmacological treatments also show some evidence for improving PTSD symptoms (Jonas et al., 2013).”
PTSD in Primary Care—An Update on Evidence-based Management
Sonis, J. H. (2013) · Current Psychiatry Reports · doi:10.1007/s11920-013-0373-4 · Cited by 15
Self-citationShiner, B. R., Leonard, C. E., Gui, J., Cornelius, S. L., Gradus, J. L., Schnurr, P. P., & Watts, B. V. (2020) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-020-01047-w · Cited by 14
“First, a 2013 Agency for Healthcare Research and Quality (AHRQ) network metaanalysis of published RCTs concluded that paroxetine and topiramate were most effective, but that fluoxetine, sertraline, and venlafaxine were also effective (Jonas et al. 2013).”
BackgroundMethodA Review of MDMA-Assisted Therapy for Posttraumatic Stress Disorder
Lewis, B. R., & Byrne, K. (2023) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20220088 · Cited by 16
Metadata
- Authors
- Jonas, D. E., Cusack, K., Forneris, C., Wilkins, T. M., Sonis, J., Middleton, J. C., Feltner, C., Meredith, D., Cavanaugh, J., Brownley, K. A., Olmsted, K. R., Greenblatt, A., Weil, A., & Gaynes, B. N.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- ORCID
- Venue
- PsycEXTRA Dataset
- Published
- 2013
- OpenAlex
- W1511020442
- Cited by
- 178
- References
- 26
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 4 · 2023: 14 · 2022: 8 · 2021: 21 · 2020: 18 · 2019: 14 · 2018: 21 · 2017: 21 · 2016: 22 · 2015: 11 · 2014: 10 · 2013: 5
- Type
- dataset
- Language
- en
- Open access
- closed
- Locations
- PsycEXTRA Dataset (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Keywords
- post-traumatic stress disorder, psychological intervention, pharmacotherapy, exposure therapy, cognitive processing therapy, cognitive behavioral therapy, EMDR, narrative exposure therapy, selective serotonin reuptake inhibitors, paroxetine, venlafaxine, topiramate, risperidone, depression, functional disability, comparative effectiveness, treatment harms, network meta-analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.